Loading...
Rising Global Controls And Biosimilar Risks Will Squeeze Margins
AnalystLowTarget's Fair Value
CHF 104.37
38.6% overvalued intrinsic discount04 Sep
CHF 144.70
1Y
82.1%7D
3.7%1Y
82.1%7D
3.7%Edit anytime before Sep 1 10:12 PM. Then post Updates to your followers.